Immutep Secures United States Patent For Eftilagimod Alpha In Combination With A PD-1 Pathway Inhibitor

NEXT STORY
Predictive Oncology Announces Cancellation of Special Meeting in December 2020
PREV STORY
VAXIL Provides Update on USAMRIID and Oral Experiments
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Innovation Pharma Announces New Brilacidin Antiviral Research on Non-SARS-CoV-2 Endemic Viral Diseases to be Presented at the 2021 Military Health System Research Symposium

author_avatar
NASDAQ Market News

NewLink Genetics Provides Corporate Update and Reports Second Quarter 2019 Financial Results

author_avatar
NASDAQ Market News

Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of Medicine

author_avatar
NASDAQ Market News